Cargando…
ABI1‐based expression signature predicts breast cancer metastasis and survival
Despite the current standard of care, breast cancer remains one of the leading causes of mortality in women worldwide, thus emphasizing the need for better predictive and therapeutic targets. ABI1 is associated with poor survival and an aggressive breast cancer phenotype, although its role in tumori...
Autores principales: | Regua, Angelina, Papp, Csaba, Grageda, Andre, Porter, Baylee A., Caza, Tiffany, Bichindaritz, Isabelle, Krendel, Mira, Sivapiragasam, Abirami, Bratslavsky, Gennady, Kuznetsov, Vladimir A., Kotula, Leszek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297774/ https://www.ncbi.nlm.nih.gov/pubmed/34967509 http://dx.doi.org/10.1002/1878-0261.13175 |
Ejemplares similares
-
Structure and Function of the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer
por: Porter, Baylee A., et al.
Publicado: (2019) -
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
por: Nath, Disharee, et al.
Publicado: (2019) -
Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer
por: Gleicher, Stephanie, et al.
Publicado: (2021) -
In Vivo Models for Prostate Cancer Research
por: Adamiecki, Robert, et al.
Publicado: (2022) -
Targeting Hsp90 in urothelial carcinoma
por: Chehab, Mahmoud, et al.
Publicado: (2015)